Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,396,709
-$2,715,927 QoQ
Shares Held
980,479
0.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#42
of 1,033 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Dec 31, 2025CallValue
$1,382,928
CallShares
28,200
PutValue
$1,196,576
PutShares
24,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. GSK ranks #1 (35.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
This page
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in GSK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,396,709 | 980,479 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $54,112,636 | 980,479 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,196,576 | 24,400 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $1,382,928 | 28,200 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $16,586,474 | 384,302 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $1,217,112 | 28,200 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $1,053,104 | 24,400 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $14,757,196 | 384,302 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $1,255,680 | 32,700 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $1,816,320 | 47,300 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $14,887,859 | 384,302 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,997,093 | 384,302 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $82,544,568 | 2,019,192 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $128,261,133 | 3,331,458 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $52,827,972 | 1,232,283 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $356,400 | 10,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $355,800 | 10,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,166,584 | 118,571 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,207,824 | 346,851 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||